Source: Annual Congress 2003 - Sleep related breathing disorders and other diseases
Disease area: Airway diseases, Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
G. Cremona, B. Mastropasqua, A. De Gaetano, E. Burlone, C. Leone, A. Pelucchi, D. Olivieri, A. Foresi (Milan, Rome, Italy). Alveolar but not airway fractional exhaled nitric oxide concentration (FENO) is decreased in obstructive sleep apnea syndrome (OSAS). Eur Respir J 2003; 22: Suppl. 45, 2955

Member's Comments

No comment yet.

Related content which might interest you: Concentration of exhaled nitric oxide (FENO) in patients with obstructive sleep apnea Source: Eur Respir J 2004; 24: Suppl. 48, 118s Year: 2004 The influence of short-term therapy of continous positive airway pressure (CPAP) on exhaled nitric oxide concentration (FENO) in patients with obstructive sleep apnea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 357s Year: 2005 Effect of nasal CPAP on exhaled nitric oxide in patients with obstructive sleep apnea Source: Eur Respir J 2007; 30: Suppl. 51, 332s Year: 2007 impact of continous positive airway pressure therapy on exhaled nitic oxide in obstructive sleep apnea syndrome Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation Year: 2019 Exhaled nitric oxide is not altered in patients with obstructive sleep apnea syndrome Source: Annual Congress 2007 - Airway regulation, provocation and monitoring II Year: 2007 Increased alveolar nitric oxide by trumpet model in patients with obstructive sleep apnoea Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Exhaled nitric oxide in obstructive sleep apnea (OSA) patients: short and long term response to automatic positive airway pressure (APAP) therapy Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007 Decreased plasma levels of nitric oxide (NO) derivatives in obstructive sleep apnea (OSA): response to automatic positive airway pressure (APAP) therapy Source: Eur Respir J 2007; 30: Suppl. 51, 332s Year: 2007 Oxydative stress in obstructive sleep apnea: Value of fractional exhaled nitric oxide measurement Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality Year: 2018 Diurnal variation of exhaled nitric oxide in obstructive sleep apnea syndrome and healthy subjects Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008 Oral nitric oxide in obstructive sleep apnoea (OSA) Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008 Nitric oxide in airways of patients with obstructive sleep apnea Source: Eur Respir J 2005; 26: Suppl. 49, 356s Year: 2005 Obstructive sleep apnoea, inspiratory flows and exhaled nitric oxide Source: Eur Respir J 2006; 28: Suppl. 50, 415s Year: 2006 Is Fractional exhaled nitric oxide (FeNO) test reliable in the differentiation of chronic obstructive pulmonary disease (COPD) and ACOS (asthma-COPD overlap syndrome)? Source: International Congress 2017 – Lung function testing in different patient categories Year: 2017 Increased alveolar nitric oxide concentration in asthmatic patients with nocturnal symptoms Source: Eur Respir J 2002; 20: 841-845 Year: 2002 Factors influencing airway inflammation measured by exhaled NO levels in a population with obstructive sleep apnea syndrome (OSA) Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010 Can fractional exhaled nitric oxide be useful to differentiate asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) from COPD-only Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Using fractional exhaled nitric oxide level to differentiate asthma–COPD overlap syndrome from COPD Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018 Increased bronchial but not alveolar exhaled nitric oxide is associated with snoring Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008 Oxydative stress in obstructive sleep apnea (OSA). Exhaled breath condensate (EBC) measurements (H2O2) in the follow-up of patients under CPAP. First results Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007